Manufacturing Standards Deadline Set for Indian Pharmaceutical Companies Amid International Drug Controversy
Indian pharmaceutical companies are facing new manufacturing standards set by the central government, following a series of overseas deaths linked to Indian-made drugs since 2022. The government’s move comes as a response to the need to improve the image of the $50 billion industry, which has been under scrutiny due to quality and safety concerns. According to a notification dated December 28, manufacturers are mandated to take responsibility for the quality of pharmaceutical products, ensuring …